{"version":"1.0","provider_name":"Amorchem","provider_url":"https:\/\/amorchem.com\/fr\/","author_name":"olabso","author_url":"https:\/\/amorchem.com\/fr\/author\/olabso\/","title":"S1009 - Amorchem","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"GeJwx0fBAi\"><a href=\"https:\/\/amorchem.com\/fr\/portfolio\/s1009\/\">S1009<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/amorchem.com\/fr\/portfolio\/s1009\/embed\/#?secret=GeJwx0fBAi\" width=\"600\" height=\"338\" title=\"&#8220;S1009&#8221; &#8212; Amorchem\" data-secret=\"GeJwx0fBAi\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/amorchem.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Ce projet provient du laboratoire du Dr Philippe Tessier \u00e0 l\u2019Universit\u00e9 Laval et de sa compagnie en d\u00e9marrage, InflammatoRx. Le projet implique la validation d\u2019un anticorps monoclonal visant une nouvelle cible dans l\u2019inflammation chronique, soit la prot\u00e9ine S100A9. Les donn\u00e9es pr\u00e9cliniques indiquent que les anticorps ciblant S100A9 peuvent bloquer la r\u00e9ponse inflammatoire de fa\u00e7on comparable [&hellip;]"}